Compare EVTC & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVTC | AXGN |
|---|---|---|
| Founded | 1988 | N/A |
| Country | United States | United States |
| Employees | N/A | 452 |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | 2013 | N/A |
| Metric | EVTC | AXGN |
|---|---|---|
| Price | $28.52 | $31.24 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $35.80 | $33.67 |
| AVG Volume (30 Days) | 476.1K | ★ 922.8K |
| Earning Date | 11-06-2025 | 10-29-2025 |
| Dividend Yield | ★ 0.69% | N/A |
| EPS Growth | ★ 76.90 | N/A |
| EPS | ★ 2.26 | N/A |
| Revenue | ★ $903,381,000.00 | $214,709,000.00 |
| Revenue This Year | $11.45 | $21.60 |
| Revenue Next Year | $5.44 | $15.83 |
| P/E Ratio | $12.86 | ★ N/A |
| Revenue Growth | 9.67 | ★ 18.72 |
| 52 Week Low | $26.72 | $9.22 |
| 52 Week High | $38.56 | $34.24 |
| Indicator | EVTC | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 42.85 | 54.51 |
| Support Level | $28.99 | $32.03 |
| Resistance Level | $29.71 | $33.84 |
| Average True Range (ATR) | 0.62 | 1.39 |
| MACD | -0.04 | -0.28 |
| Stochastic Oscillator | 7.06 | 43.83 |
Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. It derives maximum revenue from Latin America Payments and Solutions. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.